Article
KLRG1-deficient CAR-T cells exhibit superior antitumor efficacy against colorectal cancer cell lines by modulating the ZAP70/ERK signaling axis
2026-02-12
Abstract excerpt
<title>Abstract</title> <p>The incidence of colorectal cancer (CRC) is on the rise globally, necessitating new treatment options. CRC cells highly express cadherins, which can suppress CAR-T cell function by engaging the inhibitory receptor KLRG1. The current study aimed to enhance CAR-T cell therapy by targeting the inhibitory axis mentioned. To achieve this, a KLRG1-downregulated CAR-T cell product (shK1-CAR-T)...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 8cc1e968-0ea5-5379-bfc7-14f9556d4b7a
- DOI
- 10.21203/rs.3.rs-8827661/v1
